Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Patients treated conservatively with moderate-high risk breast cancer were treated with IMRT plus concomitant boost to surgical bed (up to a dose of 50 Gy to whole breast and 60 Gy to the tumor bed).
Aim of the study was to evaluate late toxicity and local control after this treatment compared with a historical control group (CG) of patients treated with 3D-conformal postoperative radiotherapy delivered with conventional fractionation.
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
histologically confirmed invasive breast cancer (pT1-4) with at least one of these characteristics: 3 or more metastatic axillary nodes, pre or peri-menopausal status, close resection margins
breast conservative surgery
You may not be if
positive margins
distant metastases
Clareo Health | Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer
